MISSISSAUGA, ON--(Marketwired - July 06, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) gave an update on recent business developments today, announcing that its European pharmacy-focused channel partner commenced a mole-scanning pilot, using MedX's SIAscopy technology, in 25 Alphega Pharmacies in the United Kingdom. The mole-scanning service is based on the successful model in place in 100 Norwegian Boots pharmacies, as well as in a Swedish pharmacy chain where the mole-scanning service has recently grown to 32...
↧